State of Wisconsin Investment Board’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

State of Wisconsin Investment Board’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,400	Closed	-$346K	–	2232
2021 Q3	$346K	Hold	30,400	–	–	﹤0.01%	1835
2021 Q2	$545K	Hold	30,400	–	–	﹤0.01%	1665
2021 Q1	$471K	Hold	30,400	–	–	﹤0.01%	1617
2020 Q4	$371K	Sell	30,400 -3,800	-11%	-$53K	﹤0.01%	1624
2020 Q3	$439K	Buy	+34,200	New	+$295K	﹤0.01%	1530
2019 Q3	–	Sell	-12,575	Closed	-$209K	–	1589
2019 Q2	$209K	Buy	12,575 +275	+2%	+$4.78K	﹤0.01%	1484
2019 Q1	$206K	Buy	12,300 +2,825	+30%	+$40.7K	﹤0.01%	1460
2018 Q4	$109K	Hold	9,475	–	–	﹤0.01%	1493
2018 Q3	$379K	Buy	+9,475	New	+$270K	﹤0.01%	1441

Other funds holding MRNS

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

State of Wisconsin Investment Board's MRNS Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2021, closing a stake of 30,400 shares — an estimated $346K sold.

State of Wisconsin Investment Board first reported a position in MRNS in Q3 2018 and held it in 9 quarters. The position peaked at $545K in Q2 2021. 75 funds tracked by Wall St. Rank hold MRNS as of Q4 2021.

State of Wisconsin Investment Board reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 30,400 Marinus Pharmaceuticals, Inc shares in Q4 2021, an estimated $346K.
State of Wisconsin Investment Board first reported a position in Marinus Pharmaceuticals, Inc in Q3 2018 and held it in 9 quarters.
State of Wisconsin Investment Board's Marinus Pharmaceuticals, Inc position peaked at $545K in Q2 2021.
75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.